In this section of the page, you will find all the information you need to understand how UCB (UCB) dividends work. In addition, you will be able to consult the payment date, the ex-dividend date, the last day to be entitled to the payment, the money to be received per share, the yield and any other doubts that may arise.
UCB will distribute 1,24 euros per share in the form of a dividend on May 2, 2024.
The April 26, 2024 is the ex-dividend date. So if you wish to receive UCB dividends, you must buy one day before this date.
UCB distributed 1.33 euros per share in the form of a dividend on May 3, 2023.
UCB S.A., listed on the stock exchanges of Brussels, Frankfurt, Vienna, BATS EU, OTC market, London and TradeGate, recognized with the stock exchange symbol UCB, has a track record of more than twenty years paying dividends to its shareholders without suspensions, starting in 1999 and has remained stable and consistent to date.
The value of the amount delivered has been maintained in a very approximate range for several periods, being settled in a single annual installment, usually granted in the first days of May, reaching a yield of approximately 1.20%.
Join +33,000 investors who get notifications, analysis and news.
Payout Ratio UCB Dividends
Dividend calendar of UCB
This is the Dividend Calendar of UCB in 2023.
|Last trading date||April 25, 2024|
|Ex-Dividend (Ex-Date)||April 26, 2024|
|Record date||May 1, 2024|
|Date of payment||May 2, 2024|
Historical annual dividend yields of UCB
Dividend yield of UCB vs. the sector
Dividend yield history in UCB
Dividend history of UCB
In this table you can see the dividend history of UCB:
|2023||04/28/2023||1.33 €||1.33 €|
|2022||04/29/2022||1.3 €||1.3 €|
|2021||04/30/2021||1.27 €||1.27 €|
|2020||05/04/2020||1.24 €||1.24 €|
|2019||04/26/2019||1.21 €||1.21 €|
|2018||04/27/2018||1.18 €||1.18 €|
|2017||04/28/2017||1.15 €||1.15 €|
|2016||04/29/2016||1.1 €||1.1 €|
|2015||05/04/2015||1.06 €||1.06 €|
|2014||04/29/2014||1.04 €||1.04 €|
|2013||05/02/2013||1.02 €||1.02 €|
|2012||04/27/2012||1. €||1 €|
|2011||05/02/2011||0.98 €||0.98 €|
|2009||05/05/2009||0.92 €||0.92 €|
|2008||04/28/2008||0.92 €||0.92 €|
|2007||04/30/2007||0.9 €||0.9 €|
|2006||06/16/2006||0.88 €||0.88 €|
|2005||06/17/2005||0.86 €||0.86 €|
|2001||06/14/2001||0.64 €||0.64 €|
|2000||06/14/2000||0.5 €||0.5 €|
UCB dividend capture strategy
Information about UCB
UCB S.A., a company dedicated to the health industry, specializing in the development of pharmaceutical products to treat serious, immunological and neurological diseases, with headquarters in Belgium, is present in 40 countries, with more than 8 thousand employees, registering 5.5 billion euros in sales in 2022.
It was founded in 1928 by Emmanuel Janssen, which was initially dedicated to the creation of industrial chemicals, being one of the first to distill ammonia from coal, also including a pharmaceutical laboratory, in 1950 created a research and development center where they produce key drugs for the company as Atarax, Piracetam or Nootropil and Zyrtec or cetirizine.
In 2002 they merged their previous activities and added others such as the creation of resins and additives, splitting the chemicals division in 2004, when they acquired the biotechnology company Celltech, in 2019 they bought Ra Pharma, a specialist in immunological diseases, and in 2022 they acquired Zogenix, remaining exclusively in the pharmaceutical sector.
The main products for which UCB is recognized are Atarax, Briviact, Nootropil, Zyrtec and Xyzal antihistamines, Keppra and Cimzia anticonvulsant drugs for the treatment of epilepsy, Vimpat an anticonvulsant, Atamet and Neupro used for Parkinson's disease.
Frequently asked questions about UCB dividends
UCB pays dividends on a Annual basis.
UCB is listed on the Bolsa de Bruselas and is part of the BEL20.
UCB has the Ticker or stock code UCB.
UCB belongs to the Health Care sector and the Biotechnology industry.
The CEO of UCB in 2023 is Mr. Jean-Christophe Tellier.
At this moment, the value of a UCB share is 74.22€.
UCB has a growing dividend program. In the last 5 years, dividends have been at least equal to or higher than the previous year.